欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号HU/H/0890/002
药品名称Nilotinib Viatris 150 mg hard capsule
活性成分
    • Nilotinib 150.0 mg
剂型Capsule, hard
上市许可持有人Viatris Ltd Damastown Industrial Park Mulhuddart, Dublin 15 Dublin, Ireland E-mail: mylanireland.mahs@viatris.com
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Greece (GR)
    • Norway (NO)
    • Germany (DE)
      Nilotinib Viatris Hartkapseln 150 mg
    • Poland (PL)
      Nilotinib Viatris
    • Denmark (DK)
      Nilotinib Viatris
    • Bulgaria (BG)
      Nilotinib Viatris
    • Belgium (BE)
    • Cyprus (CY)
      Nilotinib/Viatris Capsules hard, 150 mg/cap
    • Netherlands (NL)
      Nilotinib Viatris 150 mg, harde capsules
    • Czechia (CZ)
      Nilotinib Viatris
    • Luxembourg (LU)
    • Slovakia (SK)
    • Iceland (IS)
    • Malta (MT)
    • Austria (AT)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
许可日期2024/05/28
最近更新日期2025/09/19
药物ATC编码
    • L01EA03 nilotinib
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase